Public Consultation on Authority Required Medicines for the Post-market Review of Authority Required PBS Listings
Page last updated: 4 March 2015
The call for public submissions addressing the Authority Required medicines closed on 8 October 2014. The Department appreciates the contribution of all organisations and individuals who made a submission.
- The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
- The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
- The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquiries and assessments about those matters or seek independent advice.
- Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.
Unless otherwise requested, submissions addressing the Post-market Review of Authority Required PBS Listings have been published below.
The Department of Health will not publish submissions, or parts of submissions, which contain personal information, offensive language, potentially defamatory material or copyright infringing material.
Responsibility for copyright in submissions resides with the author(s), not with the Department of Health.
All submissions have been converted to Portable Document Format (PDF) for publication and may have a different appearance to the document that was submitted.
Table of Submissions
|Submission||Author Name||Document link||Date Received|
|1||Prospection Pty Ltd||Submission 1 (PDF 282KB)||20/08/2014|
|2||Dr Irwin Lim||Submission 2 (PDF 242KB)||18/09/2014|
|3||Dr Paul Kubler||Submission 3 (PDF 109KB)||18/09/2014|
|4||Medication Services Queensland , Queensland Health||Submission 4 (PDF 179KB)||22/09/2014|
|5||Nicole Walker, Department of Gastroenterology, Gold Coast University Hospital||Submission 5 (PDF 110KB)||24/09/2014|
|6||Individual Professional||Not for publication||25/09/2014|
|7||Pulmonary Hypertension Society of Australia and New Zealand Inc||Submission 7 (PDF 433KB)||30/09/2014|
|8||Dr Warren Weightman||Not for publication||01/10/2014|
|9||Optometry Australia||Submission 9 (PDF 626KB)||03/10/2014|
|10||Biogen Idec Australia Pty Ltd||Submission 10 (PDF 585KB)||03/10/2014|
|11||Hilton Francis & Associates||Submission 11 (PDF 122KB)||03/10/2014|
|12||Aspen Pharmacare Australia Pty Ltd||Not for publication||03/10/2014|
|13||Individual Professional||Not for publication||06/10/2014|
|14||Individual Professional||Not for publication||06/10/2014|
|15||Individual Professional||Not for publication||07/10/2014|
|16||Society of Hospital Pharmacists of Australia (SHPA)||Submission 16 (PDF 381KB)||07/10/2014|
|17||Industry Organisation||Not for publication||07/10/2014|
|18||Individual Professional||Not for publication||07/10/2014|
|19||Individual Professional||Not for publication||07/10/2014|
|20||Mr Tim Hewlett||Submission 20 (PDF 1.7MB)||07/10/2014|
|21||Individual Professional||Not for publication||07/10/2014|
|22||MS Research Australia||Submission 22 (PDF 230KB)||08/10/2014|
|23||Individual Professional||Submission 23 (PDF 1MB)||08/10/2014|
|24||Pfizer Australia||Submission 24 (PDF 1.2MB)||08/10/2014|
|25||Novartis Pharmaceuticals Australia Pty Ltd||Submission 25 (PDF 508KB)||08/10/2014|
|26||Actelion Pharmaceuticals Australia Pty Ltd||Not for publication||08//10/2014|
|27||Australian Medical Association Victoria||Submission 27 (PDF 204KB)||08/10/2014|
|28||Individual Professional||Submission 28 (PDF 121KB)||08/10/2014|
|29||Individual Professional||Submission 29 (PDF 7.4MB)||08/10/2014|
|30||Bayer Australia Limited||Submission 30 (PDF 526KB)||08/10/2014|
|31||Icon Cancer Care||Submission 31 (PDF 584KB)||08/10/2014|
|32||LEO Pharma Pty Ltd||Submission 32 (PDF 463KB)||08/10/2014|
|33||Medicines Australia||Submission 33 (PDF 364KB)||08/10/2014|
|34||AbbVie Pty Ltd||Submission 34 (PDF 1MB)||08/10/2014|
|35||Nutricia Advanced Medical Nutrition||Submission 35 (PDF 209KB)||08/10/2014|
|36||Allergan Australia Pty Ltd||Not for publication||08/10/2014|
|37||GlaxoSmithKline Australia||Submission 37 (PDF 548KB)||08/10/2014|
|38||Australian Medical Association||Submission 38 (PDF 225KB)||08/10/2014|
|39||Individual Professional||Not for publication||08/10/2014|
|40||Royal Australian & New Zealand College of Ophthalmologists (RANZCO)||Submission 40 (PDF 7.3MB)||08/10/2014|
|41||Ipsen Pty Ltd||Not for publication||08/10/2014|
|42||Radien Dermatology Gordon||Submission 42 (PDF 288KB)||08/10/2014|
|43||Industry Organisation||Not for publication||08/10/2014|
|44||Individual Professional||Not for publication||08/10/2014|
|45||AstraZeneca||Submission 45 (PDF 428KB)||08/10/2014|
|46||Danone Nutricia Early Life Nutrition||Submission 46 (PDF 378KB)||08/10/2014|
|47||Individual Professional||Not for publication||08/10/2014|
|48||The Pharmacy Guild of Australia||Submission 48 (PDF 16.9MB)||08/10/2014|
|49||Pharmaceutical Society of Australia||Submission 49 (PDF 1MB)||09/10/2014|
|50||Macular Disease Foundation Australia||Submission 50 (PDF 1.4MB)||16/10/2014|